Karsten Krueger , Mark Bendel , Markus Zaehringer , Guido Reinicke , Klaus Lackner
{"title":"中心血管内照射预防血液透析患者血管成形术后动静脉瘘再狭窄","authors":"Karsten Krueger , Mark Bendel , Markus Zaehringer , Guido Reinicke , Klaus Lackner","doi":"10.1016/j.carrad.2004.02.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To report follow-up results of a prospective trial on centered endovascular gamma-irradiation (CEGI) after percutaneous transluminal angioplasty (PTA) for stenosis of arteriovenous fistula in hemodialysis patients.</p></div><div><h3>Methods and materials</h3><p>Eight patients receiving PTA for recurrent (<em>n</em>=4) or de novo arteriovenous fistula stenoses were treated with CEGI with iridium-192 (14 Gy). Angiography was performed after 6 and 12 months or if problems reoccurred during hemodialysis. Parameters of hemodialysis and duplex sonography were determined the day before and after PTA and after 1, 3, 6, 9, and 12 months.</p></div><div><h3>Results</h3><p>CEGI was performed successfully and without complications in seven patients. In six patients, restenosis occurred 6–52 weeks (mean 20.8±17.9 weeks) after PTA and required PTA. Parameters of hemodialysis and duplex sonography deteriorated during follow-up.</p></div><div><h3>Conclusions</h3><p>Centered endovascular gamma-irradiation with iridium 192 immediately after PTA of fistula stenoses was a safe and feasible method but did not prevent restenosis.</p></div>","PeriodicalId":80261,"journal":{"name":"Cardiovascular radiation medicine","volume":"5 1","pages":"Pages 1-8"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.carrad.2004.02.005","citationCount":"4","resultStr":"{\"title\":\"Centered endovascular irradiation to prevent postangioplasty restenosis of arteriovenous fistula in hemodialysis patients\",\"authors\":\"Karsten Krueger , Mark Bendel , Markus Zaehringer , Guido Reinicke , Klaus Lackner\",\"doi\":\"10.1016/j.carrad.2004.02.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>To report follow-up results of a prospective trial on centered endovascular gamma-irradiation (CEGI) after percutaneous transluminal angioplasty (PTA) for stenosis of arteriovenous fistula in hemodialysis patients.</p></div><div><h3>Methods and materials</h3><p>Eight patients receiving PTA for recurrent (<em>n</em>=4) or de novo arteriovenous fistula stenoses were treated with CEGI with iridium-192 (14 Gy). Angiography was performed after 6 and 12 months or if problems reoccurred during hemodialysis. Parameters of hemodialysis and duplex sonography were determined the day before and after PTA and after 1, 3, 6, 9, and 12 months.</p></div><div><h3>Results</h3><p>CEGI was performed successfully and without complications in seven patients. In six patients, restenosis occurred 6–52 weeks (mean 20.8±17.9 weeks) after PTA and required PTA. Parameters of hemodialysis and duplex sonography deteriorated during follow-up.</p></div><div><h3>Conclusions</h3><p>Centered endovascular gamma-irradiation with iridium 192 immediately after PTA of fistula stenoses was a safe and feasible method but did not prevent restenosis.</p></div>\",\"PeriodicalId\":80261,\"journal\":{\"name\":\"Cardiovascular radiation medicine\",\"volume\":\"5 1\",\"pages\":\"Pages 1-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.carrad.2004.02.005\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular radiation medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1522186504000113\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular radiation medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1522186504000113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Centered endovascular irradiation to prevent postangioplasty restenosis of arteriovenous fistula in hemodialysis patients
Purpose
To report follow-up results of a prospective trial on centered endovascular gamma-irradiation (CEGI) after percutaneous transluminal angioplasty (PTA) for stenosis of arteriovenous fistula in hemodialysis patients.
Methods and materials
Eight patients receiving PTA for recurrent (n=4) or de novo arteriovenous fistula stenoses were treated with CEGI with iridium-192 (14 Gy). Angiography was performed after 6 and 12 months or if problems reoccurred during hemodialysis. Parameters of hemodialysis and duplex sonography were determined the day before and after PTA and after 1, 3, 6, 9, and 12 months.
Results
CEGI was performed successfully and without complications in seven patients. In six patients, restenosis occurred 6–52 weeks (mean 20.8±17.9 weeks) after PTA and required PTA. Parameters of hemodialysis and duplex sonography deteriorated during follow-up.
Conclusions
Centered endovascular gamma-irradiation with iridium 192 immediately after PTA of fistula stenoses was a safe and feasible method but did not prevent restenosis.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
